Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 100 19 7?
Displaying drugs 3351 - 3351 of 3351 in total
GO-203-2C is under investigation in clinical trial NCT02204085 (A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Investigational
Matched Iupac: … }-1-hydroxypentylidene]amino}-1-hydroxypentylidene]amino}-1-hydroxypentylidene]amino}-6,9-dihydroxy-7- …
Displaying drugs 3351 - 3351 of 3351 in total